FRM
Fox Run Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,646
| Closed | -$643K | – | 1173 |
|
|
2025
Q1 | $643K | Sell |
20,646
-34,416
| -63% | -$1.07M | 0.1% | 382 |
|
|
2024
Q4 | $1.4M | Buy |
55,062
+16,084
| +41% | +$410K | 0.26% | 69 |
|
|
2024
Q3 | $1.1M | Buy |
38,978
+1,383
| +4% | +$39.1K | 0.25% | 92 |
|
|
2024
Q2 | $991K | Buy |
37,595
+12,508
| +50% | +$330K | 0.19% | 189 |
|
|
2024
Q1 | $762K | Buy |
+25,087
| New | +$762K | 0.16% | 230 |
|
|
2023
Q3 | – | Sell |
-7,750
| Closed | -$238K | – | 952 |
|
|
2023
Q2 | $238K | Sell |
7,750
-15,703
| -67% | -$483K | 0.07% | 524 |
|
|
2023
Q1 | $845K | Buy |
23,453
+13,919
| +146% | +$502K | 0.28% | 98 |
|
|
2022
Q4 | $377K | Buy |
+9,534
| New | +$377K | 0.15% | 264 |
|
|
2022
Q2 | – | Sell |
-14,787
| Closed | -$576K | – | 718 |
|
|
2022
Q1 | $576K | Buy |
+14,787
| New | +$576K | 0.32% | 67 |
|
|
2021
Q4 | – | Sell |
-8,659
| Closed | -$313K | – | 675 |
|
|
2021
Q3 | $313K | Buy |
+8,659
| New | +$313K | 0.2% | 214 |
|